Literature DB >> 2171189

Retrovirus vector-targeted inducible expression of human beta-interferon gene to B-cells.

J F Engelhardt1, M J Kellum, F Bisat, P M Pitha.   

Abstract

We have introduced the human beta-interferon gene with its promoter region into murine B-cell and fibroblast cell lines via a Moloney murine leukemia virus (M-MuLV) vector and have studied the inducible expression of the beta-interferon gene as a function of the various retroviral vector designs. By deleting the enhancer within the 3' viral long terminal repeat (LTR), inserting the human beta-interferon gene, and varying placement of the immunoglobulin heavy chain enhancer, we were able to construct vectors which yielded proviruses with various cell type-specific regulation. One of the vectors (pT154) led to a greater than 21-fold increase in beta-interferon protein synthesis after viral infection in the two B-cell lines analyzed, while no inducibility was seen in the fibroblast cells. The data show that inducible beta-interferon expression within a MuLV vector was highly dependent on the absence of the viral enhancer region in the long terminal repeat and the orientation of the beta-interferon gene within the proviral transcriptional unit; the insertion of the immunoglobulin enhancer elevated both constitutive and (or) inducible expression of beta-interferon in B-cells but inhibited constitutive expression of this gene in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171189     DOI: 10.1016/0042-6822(90)90339-s

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

Review 1.  Targeted vectors for gene therapy of cancer and retroviral infections.

Authors:  W Walther; U Stein
Journal:  Mol Biotechnol       Date:  1996-12       Impact factor: 2.695

2.  Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.

Authors:  W Popik; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.

Authors:  J M Pozsgay; M W Beilharz; B D Wines; A D Hess; P M Pitha
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.

Authors:  A S Pollock; D H Lovett
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

5.  Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.

Authors:  Y Su; W Popik; P M Pitha
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.